IN-SILICO PRELIMINARY DOCKING SCREENING OF SOME ANTI-ALZHEIMER DRUGS
Journal: Indian Drugs (Vol.53, No. 6)Publication Date: 2016-06-28
Authors : Sharma S.; Daniel K.; Daniel V.; Sharma L.;
Page : 74-79
Keywords : ;
Abstract
Alzheimer's disease is an irreversible, progressive brain disease that slowly destroys cognition function. It is neurodegenerative disease & most common kind of dementia. The main purpose of this work is to perform preliminary docking screening & estimate toxic properties of some anti-Alzheimer's drugs through computational software. To assess toxic properties of some anti-Alzheimer's drugs, through Lipinski rule of five. Drug-likeness and toxic properties of selective drugs were determined by employing Osiris server. To calculate the biological activity spectrum through prediction of activity spectra for a drug which provide intrinsic property that correspond to different pharmacological effects, physiological and biochemical mechanisms of action. The OSIRIS toxicity predictions resulted for toxicity, cLogP value, drug likeness and drug-score of each molecular imprint. These findings are relevant for the exploration of drug action of any compound of Anti- Alzheimer's drug using both animal models and in silico strategies.
Other Latest Articles
- IN VITRO SCREENING OF ACTINIOPTERIS DICHOTOMA FOR ENZYME INHIBITORY ACTIVITY RELATED TO TYPE 2 DIABETES
- SIMULTANEOUS ESTIMATION OF EMITRICITABINE, EFAVIRENZ, TENOFOVIR DISPROXIL FUMARATE BY CHEMOMETRY AND REVERSE PHASE-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
- STABILITY-INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF AMLODIPINE BESYLATE AND AZILSARTAN MEDOXOMIL IN TABLET DOSAGE FORM
- DEVELOPMENT OF LIQUID-LIQUID EXTRACTION PROCEDURE AND ITS APPLICATION FOR QUANTIFICATION OF ERLOTINIB IN SPIKED HUMAN PLASMA USING RP-HPLC WITH UV DETECTION
- DEVELOPMENT AND VALIDATION OF NEW RP-HPLC METHOD FOR QUANTITATIVE ESTIMATION OF VITAMIN-D3 IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM
Last modified: 2017-08-23 14:38:10